Inhibikase Therapeutics Betriebsaufwand | IKT

Betriebsaufwand Jährlich Inhibikase Therapeutics

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-	-	-	-	-	3.52 M	6.82 M	6.16 M	-	-	-	-	-	-	-

Alle Zahlen in USD-Währung

Indikatorenreichweite aus Jahresberichten

Höchstwert	Mindestwert	Durchschnitt
6.82 M	3.52 M	5.5 M

Betriebsaufwand anderer Aktien in der Pharmaeinzelhändler

Name	Betriebsaufwand	Preis	% 24h	Marktkapitalisierung	Land
Celsion Corporation CLSN	14.7 M	-	-6.63 %	$ 13.9 M	USA
I-Mab IMAB	1.49 B	-	-	$ 866 M	China
Alexion Pharmaceuticals, Inc. ALXN	2.66 B	-	-	$ 40.3 B	USA
Genfit SA GNFT	78.3 M	-	2.54 %	$ 160 B	France
CureVac N.V. CVAC	88.9 M	-	-	$ 867 M	Germany
BiondVax Pharmaceuticals Ltd. BVXV	78.4 M	-	0.74 %	$ 768 M	Israel
Abcam plc ABCM	170 M	-	-	$ 4.9 B	Britain
Midatech Pharma plc MTP	4.78 M	-	-18.52 %	$ 27.3 M	Britain
MorphoSys AG MOR	432 M	-	2.43 %	$ 254 M	Germany
Affimed N.V. AFMD	54 M	-	-34.95 %	$ 21.5 M	Germany
AnPac Bio-Medical Science Co., Ltd. ANPC	106 M	-	-1.58 %	$ 28.1 M	China
Celyad Oncology SA CYAD	26.2 M	-	-	$ 12.5 M	Belgium
Gracell Biotechnologies GRCL	214 M	-	-	$ 3.37 B	China
Galapagos NV GLPG	709 M	-	-	$ 1.83 B	Belgium
Teligent, Inc. TLGT	548 K	-	-13.85 %	$ 16.1 M	USA
Viela Bio, Inc. VIE	163 M	-	-	$ 2.91 B	USA
Aphria Inc. APHA	188 M	-	-0.45 %	$ 4.87 B	Canada
Aerpio Pharmaceuticals, Inc. ARPO	21.3 M	-	-0.90 %	$ 104 M	USA
Chiasma, Inc. CHMA	71.7 M	-	-6.00 %	$ 238 M	USA
Adamas Pharmaceuticals, Inc. ADMS	117 M	-	-	$ 376 M	USA
Cellect Biotechnology Ltd. APOP	22.3 M	-	0.38 %	$ 12.9 M	Israel
AzurRx BioPharma, Inc. AZRX	26.4 T	-	2.07 %	$ 34.4 M	USA
Cerecor Inc. CERC	53.7 M	-	-1.68 %	$ 283 M	USA
Constellation Pharmaceuticals, Inc. CNST	125 M	-	-	$ 1.63 B	USA
Auris Medical Holding Ltd. EARS	7.26 M	-	-1.77 %	$ 39.2 M	Bermuda
Dicerna Pharmaceuticals, Inc. DRNA	278 M	-	0.34 %	$ 2.98 B	USA
ERYTECH Pharma S.A. ERYP	33.8 M	-	1.3 %	$ 27.7 M	France
GW Pharmaceuticals plc GWPH	541 M	-	-	$ 6.81 B	Britain
Kadmon Holdings, Inc. KDMN	109 M	-	-	$ 1.7 B	USA
Liminal BioSciences LMNL	95.4 M	-	-	$ 256 M	Canada
Neos Therapeutics, Inc. NEOS	49.9 M	-	-2.54 %	$ 57.2 M	USA
Odonate Therapeutics, Inc. ODT	127 M	-	-3.18 %	$ 58.5 M	USA
Orphazyme A/S ORPH	336 M	-	-2.25 %	$ 31.3 M	Danmark
Osmotica Pharmaceuticals plc OSMT	102 M	-	-10.74 %	$ 89.9 M	USA
Pandion Therapeutics, Inc. PAND	46.7 M	-	-	$ 1.77 B	USA
Translate Bio, Inc. TBIO	146 M	-	-	$ 2.81 B	USA
Trillium Therapeutics Inc. TRIL	61.6 M	-	-	$ 1.94 B	Canada
Urovant Sciences Ltd. UROV	139 M	-	-	$ 532 M	Britain
Acceleron Pharma Inc. XLRN	210 M	-	-	$ 10.9 B	USA
Zealand Pharma A/S ZEAL	1.09 B	-	0.52 %	$ 821 M	Danmark
Zogenix, Inc. ZGNX	242 M	-	-4.97 %	$ 664 M	USA
Yunhong International ZGYH	309 K	-	0.10 %	$ 92.2 M	China
ZIOPHARM Oncology, Inc. ZIOP	80.4 M	-	-7.58 %	$ 264 M	USA
Leap Therapeutics LPTX	41.1 M	-	368.57 %	$ 41.9 M	USA
Cortexyme CRTX	58.1 M	-	-1.05 %	$ 67.1 M	USA
Aptorum Group Limited APM	31 K	-	-	$ 5.72 M	China
FSD Pharma HUGE	15.3 M	-	5743.5 %	$ 69.7 M	Canada
BioAtla BCAB	61.3 M	$ 1.74	0.64 %	$ 102 M	USA